🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Dylan Braun

Denali Therapeutics (United States)

ORCID: 0009-0007-1372-4736

Also affiliated with Tetra Therapeutics (United States)

NeuroscienceMedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “PILRA regulates microglial neuroinflammation and lipid metabolism as a candidate therapeutic target for Alzheimer’s disease”.

PILRA regulates microglial neuroinflammation and lipid metabolism as a candidate therapeutic target for Alzheimer’s disease

Research Square(2024)10.21203/rs.3.rs-3954863/v1

N/A

0.345DataRank · unranked

9 citations

Tanya Weerakkody, Hanna Sabelström, David Tatarakis, Jung H. Suh, Marcus Y. Chin +26 more

Decreased lipidated ApoE-receptor interactions confer protection against pathogenicity of ApoE and its lipid cargoes in lysosomes

Cell(2024)10.1016/j.cell.2024.10.027

N/A

0DataRank · unranked

86 citations

Dylan Braun, Gabriel A. Fitzgerald, Yun-Ting Hsieh, Lionel Rougé, Alexandra Litvinchuk +37 more

Loss of PILRA promotes microglial immunometabolism to reduce amyloid pathology in cell and mouse models of Alzheimer’s disease

Science Translational Medicine(2025)10.1126/scitranslmed.adw7428

N/A

0DataRank · unranked

6 citations

Hanna Sabelström, Shan V. Andrews, Jean Paul Chadarevian, Marcus Y. Chin, David Tatarakis +46 more